NIAID-Funded Adjuvant Improves Typhoid Vaccine Candidate in Animal
4.9 (260) · $ 21.50 · In stock
An investigational typhoid vaccine containing a component developed with NIAID funding may overcome some of the shortcomings of available typhoid vaccines, according to a paper published in the journal Vaccine in June.
Transcriptional correlates of malaria in RTS,S/AS01-vaccinated
Frontiers Polyphosphazenes as Adjuvants for Animal Vaccines and
Frontiers U-Omp19 from Brucella abortus Is a Useful Adjuvant for
Global Innovations (International Cooperation
Frontiers CAvant® WO-60 as an Effective Immunological Adjuvant
Salmonella Typhimurium expressing chromosomally integrated
Vaccine - Wikipedia
Frontiers Reduced immunogenicity of a live Salmonella enterica
Controlled Human Infection Models To Accelerate Vaccine
Stages in COVID-19 vaccine development: The Nemesis, the Hubris
PDF) Liposomes as immunological adjuvants and vaccine carriers
Frontiers Nanomaterials-based vaccines to target intracellular
A typhoid fever protein capsular matrix vaccine candidate
Current barriers, challenges and opportunities for the development
,aspect=fit)
